Sales Performance - Sales for the quarter were $48,393,000, a decrease of 2.9% from $49,839,000 in the comparable period of the prior year[53]. - International sales decreased by 10.7% to $12,870,000 compared to $14,419,000 in the prior year due to customer construction site delays in India[53]. Profitability - The gross profit margin increased to 25.8% for the three months ended July 31, 2024, up from 23.9% in the comparable quarter of the prior year[54]. - Net earnings were $2,193,000, or $0.74 per diluted share, down from $2,474,000, or $0.86 per diluted share, in the prior year[57]. Operating Expenses - Operating expenses rose to $9,913,000, or 20.5% of sales, compared to $8,106,000, or 16.3% of sales, in the prior year[55]. Taxation - The effective income tax rate decreased to 7.9% for the three months ended July 31, 2024, from 26.3% in the prior year, influenced by a discrete tax benefit of $421,000[56]. Order Backlog - The Company's order backlog increased to $159.4 million at July 31, 2024, compared to $140.8 million at July 31, 2023[53]. Working Capital - Working capital was $56,012,000 at July 31, 2024, compared to $56,037,000 at April 30, 2024, with a current ratio of 2.5-to-1.0[58]. - The Company used cash of $794,000 during the three months ended July 31, 2024, primarily due to decreases in accounts payable and accrued expenses[59]. Strategic Focus - The Company continues to focus on supporting its dealers and distribution channel partners domestically while providing turnkey solutions in international markets[61].

Kewaunee Scientific Corporation (KEQU) reported mixed results for first-quarter fiscal 2025, with both earnings per share (EPS) and sales declining year over year. The company faced headwinds from delayed international shipments, particularly in India, which weighed on its overall performance. However, domestic operations were stable in the quarter under review, and a growing order backlog suggests the potential for recovery in the coming quarters. Rising costs, driven by higher professional fees, also impa ...

STATESVILLE, N.C., Sept. 11, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its first quarter ended July 31, 2024. Fiscal Year 2025 First Quarter Results: Sales during the first quarter of fiscal year 2025 were $48,393,000, a decrease of 2.9% compared to sales of $49,839,000 from the prior year's first quarter. Pre-tax earnings for the quarter were $2,430,000 compared to $3,412,000 for the prior year quarter, a decrease of 28.8%. Net earnings were $2,193,000 ...

STATESVILLE, N.C., Sept. 4, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU), a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products, today announces that the Company will attend the 2024 Arablab Live tradeshow and conference being held in Dubai this September 24-26. The tradeshow will welcome industry professionals from 120+ countries, bringing together leading global designers, manufacturers, and distributors i ...

STATESVILLE, N.C., Aug. 28, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its first quarter fiscal year 2025 financial results on Wednesday, September 11, 2024 after the close of trading. This information will be available on the Company's website www.kewaunee.com after the release. About Kewaunee Scientific Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of lab ...

LOS ANGELES, Aug. 8, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Kewaunee Scientific Corporation ("Kewaunee Scientific" or "the Company") (NASDAQ: KEQU) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. If you are a shareholder who suffered a loss, click he ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 __________________________ FORM 10-K __________________________ ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended April 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission file number 0-5286 KEWAUNEE SCIENTIFIC CORPORATION (Exact name of reg ...

Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III 704/871-3274 STATESVILLE, N.C. June 26, 2024 – PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its fourth quarter and its fiscal year ended April 30, 2024. Fiscal Year 2024 Fourth Quarter Results: Sales during the fourth quarter of fiscal year 2024 were $56,702,000, an increase of 5% compared to sales of $53,986,000 from the prior year's fourth ...

Total cash on hand on April 30, 2024 was $25,938,000, as compared to $13,815,000 on April 30, 2023. The increase in cash was primarily from improved operating performance. Working capital was $56,037,000, as compared to $47,867,000 on April 30, 2023. The Company had short-term debt of $3,099,000 as of April 30, 2024, as compared to $3,587,000 on April 30, 2023. Long-term debt was $28,479,000 on April 30, 2024, as compared to $29,007,000 on April 30, 2023. The building lease from the Company's December 2021 ...

STATESVILLE, N.C., June 12, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release financial results for its fourth quarter and fiscal year ended April 30, 2024 on Wednesday, June 26, 2024 after the close of trading. This information will be available on the Company's website www.kewaunee.com after the release. Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laborator ...